Open AccessP865: BIOMARKER ANALYSIS TO SUPPORT DOSE OPTIMIZATION OF IBERDOMIDE AS MONOTHERAPY AND IN COMBINATION WITH STANDARD OF CARE TREATMENTS FOR MULTIPLE MYELOMA FROM A PHASE 1/2 TRIAL
Author(s) -
Amatangelo M.,
Cheng Y.,
Pierceall W.,
Donk N. W.,
Lonial S.,
Wang M.,
Emerson J.,
Hong K.,
Maciag P.,
Peluso T.,
Gandhi A.,
Thakurta A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846340.95760.ac
Subject(s) - medicine , multiple myeloma , oncology , cereblon , pharmacology , population , pharmacokinetics , area under the curve , chemistry , ubiquitin ligase , biochemistry , environmental health , ubiquitin , gene